Incidence of second malignancies in patients with thymic carcinoma and thymic neuroendocrine tumor

ConclusionThe incidence of second malignancies in patients with thymic carcinoma and thymic NET is significantly higher than the patients in the normal population. The occurrence of second malignancies is not related to the use of different treatments. It is important to extend the follow-up period and add other screening methods.
Source: Journal of Cancer Research and Clinical Oncology - Category: Cancer & Oncology Source Type: research